However, ceramide synthase 1, which acts in both the de novo biosynthesis and the salvage pathway, catalyzing the formation of ceramide from sphinganine or sphingosine, was increased in patients with HF (CERS1: 1.98 ± 1.05, p = 0.040) (Figure 1). Here, CERS1 is linked to hydrops fetalis.